We work with innovators of biotech, digital health, medtech, science, sustainability, and advanced technology

ZingPR’s star newsmakers

Featured

From AACR poster to Clinical Leader byline (+ podcast): Etira’s biotech PR playbook

From AACR poster to Clinical Leader byline (+ podcast): Etira’s biotech PR playbook

How ZingPR turned Etira’s AACR content into editorial authority—Clinical Leader byline + podcast—while staying inside preclinical guardrails.

Positioning ORCA Minerals as a credible alternative in critical minerals biomining

Positioning ORCA Minerals as a credible alternative in critical minerals biomining

How ZingPR helped Blue Evolution strategically launch ORCA Minerals, clearly communicating its groundbreaking biomining innovation, building investor confidence, and establishing market credibility.

Angiex initiates first-in-human trial of AGX101, a novel ADC targeting TM4SF1 to disrupt tumor blood supply

Angiex initiates first-in-human trial of AGX101, a novel ADC targeting TM4SF1 to disrupt tumor blood supply

Angiex selected ZingPR to generate excitement and build momentum for the Phase 1 clinical trial of AGX101, a novel antibody-drug conjugate (ADC) designed to revolutionize cancer treatment by targeting tumor blood vessels. The campaign played a crucial role in communicating the potential of AGX101 to transform cancer treatment and attracting support for Angiex's mission.

Expanded Access Programs for ALS: how WideTrial took flight

WideTrial, a startup focused on expanded access programs (EAPs), partnered with ZingPR to announce its role in a major NIH-funded EAP for ALS. The challenge was to generate excitement while establishing credibility and navigating the constraints faced by many startups. How ZingPR helped WideTrial achieve significant media coverage in prominent publications.

ALL RIGHTS RESERVED © ZINGPR 2026